Tocainide

Tocainide
Clinical data
Trade names	Tonocard
AHFS/Drugs.com	Micromedex Detailed Consumer Information
MedlinePlus	a601248
ATC code	C01BB03 (WHO) ;
Pharmacokinetic data
Bioavailability	0.9-1 (oral)
Protein binding	10-20%
Metabolism	glucuronidation (primary)
Elimination half-life	9-14 R, 13-20 S
Excretion	30-50% urine (unchanged)
Identifiers
	IUPAC name N-(2,6-dimethylphenyl)alaninamide;
CAS Number	41708-72-9 ;
PubChem CID	38945;
IUPHAR/BPS	7309;
DrugBank	DB01056 ;
ChemSpider	35632 ;
UNII	27DXO59SAN;
KEGG	D06172 ;
ChEBI	CHEBI:9611 ;
ChEMBL	ChEMBL1762 ;
CompTox Dashboard (EPA)	DTXSID9040766 ;
ECHA InfoCard	100.050.441
Chemical and physical data
Formula	C11H16N2O
Molar mass	192.262 g·mol−1
3D model (JSmol)	Interactive image;
	SMILES O=C(Nc1c(cccc1C)C)C(N)C;
	InChI InChI=1S/C11H16N2O/c1-7-5-4-6-8(2)10(7)13-11(14)9(3)12/h4-6,9H,12H2,1-3H3,(H,13,14) ; Key:BUJAGSGYPOAWEI-UHFFFAOYSA-N ;
	(verify)

Tocainide (Tonocard) is a class Ib antiarrhythmic agent. It is no longer sold in the United States.